Publication
Radiolabeled polyethyleneiminomethyl phosphonic acid as a molecule with potential for diagnosis and therapy. Comparative study on models of bladder cancer and osteossarcoma.
dc.contributor.author | Ferreira, Sara | |
dc.contributor.author | Abrantes, Ana Margarida | |
dc.contributor.author | Brito, Ana | |
dc.contributor.author | Laranjo, Mafalda | |
dc.contributor.author | Metello, Luís F. | |
dc.contributor.author | Zeevart, Jan | |
dc.contributor.author | Louw, Werner | |
dc.contributor.author | Dormehl, Irene | |
dc.contributor.author | Botelho, Maria Filomena | |
dc.date.accessioned | 2015-07-09T16:03:14Z | |
dc.date.available | 2015-07-09T16:03:14Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Introduction: The polymer PEI-MP (polyethyleneiminomethyl phosphonic acid) that might be labeled with 99mTc and 188Re, have a strong potential for diagnosis and metabolic radiotherapy, respectively. The aim of this study was to evaluate the efficacy of 99mTc-PEI-MP for diagnosis and 188Re-PEI-MP as therapeutic agent, in a comparative study using in vitro and in vivo models of bladder cancer and osteossarcoma | eng |
dc.identifier.uri | http://hdl.handle.net/10400.22/6458 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.publisher | Springer | por |
dc.title | Radiolabeled polyethyleneiminomethyl phosphonic acid as a molecule with potential for diagnosis and therapy. Comparative study on models of bladder cancer and osteossarcoma. | por |
dc.type | other | |
dspace.entity.type | Publication | |
oaire.citation.endPage | S454 | por |
oaire.citation.startPage | S454 | por |
oaire.citation.title | European Journal of Nuclear Medicine and Molecular Imaging - 26th Annual Congress of the European Association of Nuclear Medicine | por |
oaire.citation.volume | 40 | por |
rcaap.rights | openAccess | por |
rcaap.type | other | por |